For the European pharma market, things are changing fast. The regulatory inflation and the rapidly evolving European landscape, higher barriers to enter, the focus on the product quality as well as the environmental impact of the industry keep the pharma companies on their toes. Moreover, the trade war and the unpredictable US Economy creates additional challenges, and therefore additional opportunities for the European and global companies.
In this presentation you will learn:
- All eyes on Europe and China – how will they seize the moment?
- How is EU regulation changing the competitive landscape?
- What to expect in the next decade, and how to prepare?
&nsbp;
